Recent News

Email Retrieval Alerts Could Reduce IVC Filter Complications

Posted on October 25, 2018 by Sandy Liebhard

New research suggests that automatic email alerts could help reduce complications associated with retrievable IVC filters. The emails would be directed at physicians who implant the devices, and would remind doctors when it’s time to consider removing a patient’s IVC … Continue reading →

Canadian Researchers Urge Vaccine Precautions to Avoid SIRVA

Posted on October 25, 2018 by Sandy Liebhard

Canadian researchers are working to raise awareness about SIRVA, a serious and potentially debilitating shoulder injury associated with incorrect vaccine administration. “With flu season underway both the public and healthcare providers should understand how to recognize and respond to SIRVA,” … Continue reading →

Onglyza Lawsuit Parties at Odds Over Discovery

Posted on October 24, 2018 by Sandy Liebhard

Parties to hundreds of Onglyza lawsuits undergoing coordinated pretrial proceedings in a Kentucky federal court have very different ideas as to how discovery should move forward in the multidistrict litigation. AstraZeneca Wants Onglyza Discovery to Proceed in 2 Phases Plaintiffs … Continue reading →

Federal Valsartan Lawsuit Plaintiffs Request Centralization in New Jersey

Posted on October 24, 2018 by Sandy Liebhard

A group of plaintiffs pursuing lawsuits in connect with recent valsartan recalls have proposed that all such federal claims be centralized in a single U.S. District Court for the purpose of coordinated discovery and other pretrial proceedings. In a motion … Continue reading →

Johnson & Johnson Agrees to Another Risperdal Lawsuit Settlement Days Before Trial

Posted on October 23, 2018 by Sandy Liebhard

Johnson & Johnson and its Janssen Pharmaceuticals subsidiary have agreed to settle another Risperdal gynecomastia claim, just days before the lawsuit was set to go to trial in Pennsylvania’s Philadelphia Common Pleas Court. Plaintiff Prescribed Risperdal in 2004 for Bi-Polar … Continue reading →

Judge Upholds Landmark Monsanto Roundup Verdict, Slashes Punitive Award

Posted on October 23, 2018 by Sandy Liebhard

A jury’s unanimous finding that Monsanto’s popular Roundup weed killer caused a former groundskeeper to develop terminal cancer has been upheld, after a California judge refused a defense motion for a new trial. But in her 11-page decision issued on … Continue reading →

Federal Bard Hernia Mesh Lawsuits May be Filed Directly in MDL

Posted on October 22, 2018 by Sandy Liebhard

Hernia mesh lawsuits involving C.R. Bard, Inc.’s polypropylene implants may now be filed directly in the multidistrict litigation currently underway in the U.S. District Court, Southern District of Ohio According to an Order issued by the Court on September 7th, … Continue reading →

Have Anemia? A Proton Pump Inhibitor Could be to Blame.

Posted on October 18, 2018 by Sandy Liebhard

A new study is pointing to another concerning proton pump inhibitor side effect – iron deficiency. Proton pump inhibitors – including Nexium, Prilosec, and PrevAcid — are some of the most widely-used drugs in the world. In 2013, in fact, … Continue reading →

Monsanto Roundup Lawsuit Jurors Want Landmark Cancer Verdict Upheld

Posted on October 17, 2018 by Sandy Liebhard

Jurors who recently awarded $289 million to the first plaintiff to take a Monsanto Roundup lawsuit to trial in the United States are urging a California judge to uphold their unanimous, landmark verdict. Plaintiff Dwayne Johnson, 46, a former California … Continue reading →

Heart, Blood Pressure Drug Prices Soar Following Worldwide Valsartan Recall

Posted on October 17, 2018 by Sandy Liebhard

Consumers throughout the United States are shelling out significantly more money for their heart and blood pressure drugs, thanks to a series of generic valsartan recalls that began over the summer. Valsartan Price Hikes Could Have Long-Lasting Impact According to … Continue reading →